CAM
SAGE
Cormorant Asset Management’s Sage Therapeutics SAGE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-88,700
| Closed | -$12.4M | – | 71 |
|
2019
Q3 | $12.4M | Sell |
88,700
-11,300
| -11% | -$1.59M | 0.76% | 33 |
|
2019
Q2 | $18.3M | Sell |
100,000
-30,000
| -23% | -$5.49M | 1.05% | 28 |
|
2019
Q1 | $20.7M | Sell |
130,000
-53,732
| -29% | -$8.55M | 1.4% | 26 |
|
2018
Q4 | $17.6M | Sell |
183,732
-6,268
| -3% | -$600K | 1.43% | 25 |
|
2018
Q3 | $26.8M | Sell |
190,000
-49,619
| -21% | -$7.01M | 1.74% | 20 |
|
2018
Q2 | $37.5M | Hold |
239,619
| – | – | 2.78% | 10 |
|
2018
Q1 | $38.6M | Buy |
+239,619
| New | +$38.6M | 2.88% | 7 |
|
2016
Q3 | – | Sell |
-730,000
| Closed | -$22M | – | 90 |
|
2016
Q2 | $22M | Sell |
730,000
-215,000
| -23% | -$6.48M | 3.12% | 8 |
|
2016
Q1 | $30.3M | Buy |
945,000
+630,000
| +200% | +$20.2M | 4.56% | 3 |
|
2015
Q4 | $18.4M | Buy |
315,000
+75,000
| +31% | +$4.37M | 2.2% | 12 |
|
2015
Q3 | $10.2M | Buy |
+240,000
| New | +$10.2M | 1.62% | 21 |
|
2015
Q2 | – | Sell |
-850
| Closed | -$43K | – | 84 |
|
2015
Q1 | $43K | Sell |
850
-150
| -15% | -$7.59K | 0.01% | 71 |
|
2014
Q4 | $37K | Sell |
1,000
-9,000
| -90% | -$333K | 0.01% | 69 |
|
2014
Q3 | $315K | Buy |
+10,000
| New | +$315K | 0.06% | 64 |
|